首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   584篇
  免费   12篇
  国内免费   36篇
儿科学   39篇
妇产科学   2篇
基础医学   58篇
口腔科学   8篇
临床医学   63篇
内科学   61篇
皮肤病学   8篇
神经病学   3篇
特种医学   195篇
外科学   56篇
综合类   19篇
预防医学   39篇
眼科学   10篇
药学   20篇
中国医学   1篇
肿瘤学   50篇
  2022年   2篇
  2020年   2篇
  2018年   6篇
  2017年   4篇
  2016年   5篇
  2015年   11篇
  2014年   12篇
  2013年   10篇
  2012年   8篇
  2011年   11篇
  2010年   21篇
  2009年   37篇
  2008年   23篇
  2007年   34篇
  2006年   33篇
  2005年   29篇
  2004年   18篇
  2003年   12篇
  2002年   20篇
  2001年   31篇
  2000年   9篇
  1999年   25篇
  1998年   29篇
  1997年   34篇
  1996年   23篇
  1995年   11篇
  1994年   9篇
  1993年   12篇
  1992年   12篇
  1991年   5篇
  1990年   10篇
  1989年   21篇
  1988年   20篇
  1987年   10篇
  1986年   11篇
  1985年   7篇
  1984年   3篇
  1983年   4篇
  1982年   2篇
  1981年   7篇
  1979年   6篇
  1978年   2篇
  1977年   4篇
  1975年   3篇
  1972年   2篇
  1931年   1篇
  1929年   2篇
  1927年   2篇
  1926年   7篇
  1925年   3篇
排序方式: 共有632条查询结果,搜索用时 15 毫秒
601.
用两种惊厥模型,通过跳台法和避暗法观察了临床常用的几种抗癲痫药抗惊厥作用,以及对学习记忆的影响。结果表明:对抗马桑内酯惊厥,以硝基安定和氯硝基安定效果最好,苯巴比妥及丙戊酸钠次之,酰胺咪嗪和芹菜甲素无效,而苯妥英钠及抗痫灵则能加重惊厥;在电惊厥模型中,以苯妥英钠和苯巴比妥效果最佳,丙戊酸钠及酰胺咪嗪次之,其它药物无效;除芹菜甲素外,其余七种药物均能削弱记忆获得。硝基安定和氯硝基安定可保护马桑内酯惊厥对记忆的损害,而硝基安定能加重电惊厥对记忆的损害。  相似文献   
602.
A panel of five monoclonal antibodies to surface antigens of small-cell pulmonary carcinoma was used for immunodiagnosis of metastases to the bone marrowin vitro in patients with small-cell carcinoma of the lungs. Standard cytomorphological diagnosis revealed metastases to the bone marrow in 6 out of 58 patients (10.3%). Using monoclonal antibodies, positive cells were detected in 12 (20.6%) patients, the tumor nature of the positive cells being undoubted in 7 preparations (12.6%). Five out of 6 cytologically positive cases were confirmed. Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 121, No. 4, pp. 456–458, April, 1996 Presented by N. N. Trapeznikov, Member of the Russian Academy of Medical Sciences  相似文献   
603.
脑内注射白细胞介素-1β对淋巴结细胞应激免疫抑制因子生成的影响李怡凡,左永昌,邵黎,宋德懋,丁桂凤,范少光(北京医科大学生理学系,北京医科大学免疫学系北京100083)我室以前的工作发现束缚应激后,动物血清内出现一类能抑制淋巴细胞转化的因子,进一步的...  相似文献   
604.
Medical impact of unedited preliminary radiology reports   总被引:3,自引:0,他引:3  
  相似文献   
605.
Summary Follow-up studies on 466 patients over a 5-year period showed Whites to have an overall significantly longer disease-free interval and survival than Blacks and Asians. No racial differences in prognosis were seen in patients with Stage II disease (p>0.2) but in Stage III, White patients had significantly longer disease-free periods than Blacks or Asians; the same was not true of survival. Whites had a 67% incidence of cytoplasmic estrogen receptor (CER) positive tumors compared with only 49% in Blacks and 41% in Asians. When tumors were assayed for CER, nuclear estrogen receptor (NER), and cytoplasmic progesterone receptor (CPR), there were no racial differences in the proportions of tumors containing all 3 receptors, but significant variations were found in neoplasms with no receptors and in those with apparently defective receptors. In White patients receptor status had no influence on prognosis (p>0.3). Black patients whose tumors contained both CER and NER had a significantly better time to recurrence than those whose tumors lacked these receptors, while in Asian women the presence of CER alone, or CER together with NER, or CER, NER, and CPR, was indicative of a significantly longer disease-free period.  相似文献   
606.
In several test model systems using spontaneous metastasizing experimental tumours, convincing data indicate the importance of the tumour burden left after surgery for the efficacy of the combination of surgery and chemotherapy. Early removal of the primary tumour by radical surgery for cure seems to improve the conditions for chemotherapy. Since 1979, in nine different departments of thoracic surgery, patients with small-cell carcinoma of the lung (SCCL) have been randomized after surgery for cure to receive a new sequential intermittent polychemotherapy (sq.CT) of 3 different alternating drug combinations given intermittently over 1 year, or one 4-drug combination chemotherapy (CT) given intermittently over 3 years. The calculation of their life table curves at 1 August 1984 indicated an improvement in the 4-year survival rate of 23 patients receiving sq.CT to about 50%, compared with a survival rate of about 30% for 29 patients receiving CT. The number of patients is still too small for firm conclusions to be drawn, but it is concluded that surgery for SCCL seems to be an advisable measure for the efficacy of aggressive intermittent long-term polychemotherapy. However, this can only be proved in large cooperative studies.  相似文献   
607.
The results of treatment of 69 cases of advanced soft tissue sarcomas are presented. Patients were given various drug schemes including cisplatin. Overall response in the study group was 30%. Tumor appeared sensitive to the treatment in 49%. A combination of carminomycin, methotrexate, cyclophosphamide and cisplatin proved to be the most effective (39%). The scheme was effective in both untreated patients and those previously treated with adriamycin. Hematologic toxicity registered in 67% cases was the most severe complication involved in the treatment with the above drug regimen.  相似文献   
608.
609.
The title compound was synthesized with the view of finding anticancer agents since organogermanium have been reported to have such actions. Tts structure and properties were determined and examined by elemental analysis, IR spectrum, FAB-MS and TG-DTA. The IR spectrum showed the characteristic absorption band of Ge-O bonds at 800~900 cm-1,indicating the formation of organogermanium sesquioxide. Under fast acom bombardment, the Ge-O-Ge-O network was split, the fragments with R-Ge could combine with 3-mercapto-1,2-propanediol or glycerin easily, forming the new compounds of R-Ge-O-CH and R-Ge-O-CH type. When heated in air, the compound decomposed in three steps, the possible mechanism of thermal decomposition was discussed. The biological activity of the compound is to be determined.  相似文献   
610.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号